Literature DB >> 32732248

Racial/Ethnic Differences in Ovarian Cancer Risk: Results from the Multiethnic Cohort Study.

Danja Sarink1, Anna H Wu2, Loïc Le Marchand1, Kami K White1, Song-Yi Park1, V Wendy Setiawan2, Brenda Y Hernandez1, Lynne R Wilkens1, Melissa A Merritt3.   

Abstract

BACKGROUND: Incidence rates of epithelial ovarian cancer (EOC) vary across racial/ethnic groups, yet little is known about the impact of hormone-related EOC risk factors in non-Whites.
METHODS: Among 91,625 female Multiethnic Cohort Study participants, 155 incident EOC cases were diagnosed in Whites, 93 in African Americans, 57 in Native Hawaiians, 161 in Japanese Americans, and 141 in Latinas. We used Cox proportional hazards regression models to estimate hazard ratios (HR) and 95% confidence intervals (CI) for associations between race/ethnicity and EOC risk and between hormone-related factors and EOC risk across racial/ethnic groups.
RESULTS: Compared with Whites, African Americans and Japanese Americans had a lower multivariable-adjusted EOC risk; Native Hawaiians had a suggestive higher risk. Parity and oral contraceptive (OC) use were inversely associated with EOC risk (P int race/ethnicity ≥ 0.43); associations were strongest among Japanese Americans (e.g., ≥4 vs. 0 children; HR = 0.45; CI, 0.26-0.79). Age at natural menopause and postmenopausal hormone (PMH) use were not associated with EOC risk in the overall population, but were positively associated with risk in Latinas (e.g., ≥5 years vs. never PMH use; HR = 2.13; CI, 1.30-3.49).
CONCLUSIONS: We observed strong associations with EOC risk for parity and OC use in Japanese Americans and PMH use and age at natural menopause in Latinas. However, differences in EOC risk among racial/ethnic groups were not fully explained by established hormone-related risk factors. IMPACT: Our study indicates there are racial/ethnic differences in EOC risk and risk factors, and could help improve prevention strategies for non-White women. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 32732248      PMCID: PMC7541726          DOI: 10.1158/1055-9965.EPI-20-0569

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

1.  Racial differences in ovarian cancer risk.

Authors:  R B Ness; J A Grisso; J Klapper; R Vergona
Journal:  J Natl Med Assoc       Date:  2000-04       Impact factor: 1.798

2.  Recent Trends in Ovarian Cancer Incidence and Relative Survival in the United States by Race/Ethnicity and Histologic Subtypes.

Authors:  Hyo K Park; Julie J Ruterbusch; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-27       Impact factor: 4.254

3.  Modeling and variable selection in epidemiologic analysis.

Authors:  S Greenland
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

Review 4.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

5.  Ovarian cancer statistics, 2018.

Authors:  Lindsey A Torre; Britton Trabert; Carol E DeSantis; Kimberly D Miller; Goli Samimi; Carolyn D Runowicz; Mia M Gaudet; Ahmedin Jemal; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2018-05-29       Impact factor: 508.702

6.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.

Authors:  L N Kolonel; B E Henderson; J H Hankin; A M Nomura; L R Wilkens; M C Pike; D O Stram; K R Monroe; M E Earle; F S Nagamine
Journal:  Am J Epidemiol       Date:  2000-02-15       Impact factor: 4.897

Review 7.  The genesis and evolution of high-grade serous ovarian cancer.

Authors:  David D L Bowtell
Journal:  Nat Rev Cancer       Date:  2010-10-14       Impact factor: 60.716

8.  Nightshift work and fracture risk: the Nurses' Health Study.

Authors:  D Feskanich; S E Hankinson; E S Schernhammer
Journal:  Osteoporos Int       Date:  2008-09-03       Impact factor: 4.507

9.  Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study.

Authors:  Ko-Hui Tung; Marc T Goodman; Anna H Wu; Katharine McDuffie; Lynne R Wilkens; Laurence N Kolonel; Abraham M Y Nomura; Keith Y Terada; Michael E Carney; Leslie H Sobin
Journal:  Am J Epidemiol       Date:  2003-10-01       Impact factor: 4.897

10.  Risk factors for epithelial ovarian cancer by histologic subtype.

Authors:  Margaret A Gates; Bernard A Rosner; Jonathan L Hecht; Shelley S Tworoger
Journal:  Am J Epidemiol       Date:  2009-11-12       Impact factor: 4.897

View more
  2 in total

1.  Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.

Authors:  Karen Curtin; Jennifer Anne Doherty; Mollie E Barnard; Tarun Martheswaran; Margaret Van Meter; Saundra S Buys
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

2.  Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?

Authors:  Alessandro Lavoro; Aurora Scalisi; Saverio Candido; Guido Nicola Zanghì; Roberta Rizzo; Giuseppe Gattuso; Giuseppe Caruso; Massimo Libra; Luca Falzone
Journal:  Int J Oncol       Date:  2022-04-06       Impact factor: 5.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.